It really is concluded that EAM-2201 has the prospective to result in in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and it is evaluated in pooled human liver microsomes. In vitro final results show that AM-2201 should be examined for prospective pharmacokinetic drug interactions https://am220154207.wikitidings.com/5987944/the_definitive_guide_to_mam_2201